ADENOSINE ANALOG AND ITS USE IN REGULATING THE CIRCADIAN CLOCK

WIPO Patent Application WO/2018/133854

A1

Provided are a kind of nucleoside analogue compounds, and compositions comprising these compounds and pentostatin, their use for modulating circadian rhythm, preferably, for shifting circadian phase, and methods for modulating circadian rhythm, preferably, for shifting circadian phase via these compounds or the compositions.

WO/1995/001363	METHYLPHOSPHONIC ACID ESTER, PROCESS FOR PREPARING THE SAME AND ITS USE
JP3619017	NEW ARABINOSYLADENINE DERIVATIVE

ZHANG ERQUAN (CN)
QI XIANGBING (CN)
JU DAPENG (CN)
ZHAO HAIJIAO (CN)
MEI LONG (CN)
WANG ZHIQIANG (CN)
WU QINGCUI (CN)

PCT/CN2018/073526

July 26, 2018

January 20, 2018

Click for automatic bibliography generation  

NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING (CN)

C07H19/16; A61K31/7052; A61K31/7056; A61K31/7076; A61P25/00; C07H19/00; C07H19/14; C07H19/167; C07H19/173; C07H19/20; C07H19/213

WO2017178820A1	2017-10-19
WO2007135387A1	2007-11-29

SIGWORTH, L. A. ET AL.: "Adenosine A1 receptors regulate the response of the mouse circadian clock to light", BRAIN RESEARCH, vol. 960, no. 1, 2, 31 December 2003 (2003-12-31), pages 246 - 251, XP055508455, ISSN: 0006-8993
SLOAN, B.J . ET AL.: "Effect of a novel adenosine deaminase inhibitor (co-vidarabine, co- V) upon the antiviral activity in vitro and in vivo of vidarabine (Vira-A) for DNA virus replication", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, vol. 284, 31 December 1977 (1977-12-31), pages 60 - 80, XP055505106, ISSN: 0077-8923
DATABASE REGISTRY 5 December 2011 (2011-12-05), retrieved from STN Database accession no. 1349165-21-4
See also references of EP 3571211A4

IPFAITH PARTNERS (CN)

View/Download PDF      PDF Help

Previous Patent: COMMUNICATION METHOD AND DEVICE

Next Patent: PAPER-PLASTIC PACKAGING MATERIAL HAVING PHOTON-SENSITIVE INK LAYER, PACKAGING CONTAINER, AND METHOD ...